At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
ATNF 180 Life Sciences Corp
Market Closed 06-07 16:00:00 EDT
1.62
-0.12
-6.90%
盘后1.60
-0.02-1.23%
16:54 EDT
High1.71Low1.60Vol41.19K
Open1.67D1 Closing1.74Amplitude6.33%
Mkt Cap1.53MTradable Cap1.41MTotal Shares941.60K
T/O67.60KT/O Rate4.73%Tradable Shares871.60K
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--
Psychedelic stocks fall as FDA panel rejects MDMA therapy
seekingalpha  ·  06-05
Psychedelic stocks fall as FDA panel rejects MDMA therapy
FDA advisory panel fails to endorse psychedelic MDMA therapy for PTSD
seekingalpha  ·  06-05
FDA advisory panel fails to endorse psychedelic MDMA therapy for PTSD
Psychedelic stocks mixed as FDA comments on MDMA therapy
seekingalpha  ·  05-31
Psychedelic stocks mixed as FDA comments on MDMA therapy
CureVac, Oragenics, IGM Biosciences among healthcare movers
seekingalpha  ·  05-22
CureVac, Oragenics, IGM Biosciences among healthcare movers
PLAB, MMAT and HBM among pre-market losers
seekingalpha  ·  05-22
PLAB, MMAT and HBM among pre-market losers
SYTA, DATS and CYN among mid-day movers
seekingalpha  ·  05-17
SYTA, DATS and CYN among mid-day movers
GoodRx Holdings, Seelos Therapeutics, Clever Leaves among healthcare movers
seekingalpha  ·  05-16
GoodRx Holdings, Seelos Therapeutics, Clever Leaves among healthcare movers
Psychedelic drug developers could benefit from NIH funding for chronic pain
seekingalpha  ·  04-30
Psychedelic drug developers could benefit from NIH funding for chronic pain
SINT, ATNF and RETO among mid-day movers
seekingalpha  ·  04-18
SINT, ATNF and RETO among mid-day movers
INDO, ONVO and HUSA among pre-market losers
seekingalpha  ·  04-16
INDO, ONVO and HUSA among pre-market losers
GOEV, CHEK and MESO among pre-market losers
seekingalpha  ·  03-27
GOEV, CHEK and MESO among pre-market losers
CGC, CYTO and IDN are among mid-day movers
seekingalpha  ·  03-26
CGC, CYTO and IDN are among mid-day movers
VERI, AMTX and ATNF among mid-day movers
seekingalpha  ·  03-23
VERI, AMTX and ATNF among mid-day movers
180 Life Sciences Regains Full Compliance with Nasdaq Minimum Bid Price Requirement
GlobeNewswire  ·  03-14
180 Life Sciences Regains Full Compliance with Nasdaq Minimum Bid Price Requirement
ETRN, CRDF and KC are among pre market gainers
seekingalpha  ·  03-11
ETRN, CRDF and KC are among pre market gainers
InvestorNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Plans 1-for-19 Reverse Stock Split to Regain NASDAQ Compliance
StreetInsider  ·  02-26
InvestorNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Plans 1-for-19 Reverse Stock Split to Regain NASDAQ Compliance

Introduction

Company Name.
180 Life Sciences Corp
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
180 Life Sciences Corp., a clinical stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. The company product development platforms includes fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which has completed Phase IIb clinical trials that focuses on fibrosis and anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which are synthetic pharmaceutical grade molecules close or distant analogs of non-psychoactive cannabinoids, such as CBD for the treatment of inflammatory diseases and pain; and a7nAChR platform, an immune suppressive, which is under preclinical trails that focuses on alpha 7 nicotinic acetylcholine receptor. 180 Life Sciences Corp. is headquartered in Palo Alto, California.
Issue price:
--